Literature DB >> 4190201

Australia antigen and smooth-muscle antibody in acute and chronic hepatitis.

R Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4190201      PMCID： PMC7134820          DOI： 10.1016/s0140-6736(70)91605-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Cryoproteinemias. 1. The characterization and assay of cryofibrinogen.

Authors:  S E RITZMANN; C HAMBY; R COOPER; W C LEVIN
Journal:  Tex Rep Biol Med       Date:  1963

2.  Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells.

Authors:  S Whittingham; I R Mackay; J Irwin
Journal:  Lancet       Date:  1966-06-18       Impact factor: 79.321

3.  Australia antigen in chronic active liver disease with cirrhosis.

Authors:  G L Gitnick; G J Gleich; L J Schoenfield; A H Baggenstoss; A I Sutnick; B S Blumberg; W T London; W H Summerskill
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

4.  Hepatitis-associated antigen in chronic liver disease.

Authors:  R A Fox; S P Niazi; S Sherlock
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

5.  Australia antigen in acute and chronic liver disease.

Authors:  R Wright; R W McCollum; G Klatskin
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

6.  Hepatitis and leukemia: their relation to Australia antigen.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Bull N Y Acad Med       Date:  1968-12

7.  Antibody to smooth muscle in patients with liver disease.

Authors:  G D Johnson; E J Holborow; L E Glynn
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

8.  Australia antigen in chronic hepatitis in Australia.

Authors:  J D Mathews; I R Mackay
Journal:  Br Med J       Date:  1970-01-31

9.  Presence of particles other than the Australia-SH antigen in a case of chronic active hepatitis with cirrhosis.

Authors:  A J Zuckerman; P E Taylor; J D Almeida
Journal:  Br Med J       Date:  1970-01-31
  9 in total
  13 in total

1.  Trigger factors and HL-A antigens in chronic active hepatitis.

Authors:  J Lindberg; A Lindholm; P Lundin; S Iwarson
Journal:  Br Med J       Date:  1975-10-11

2.  T and B lymphocytes in patients with chronic active hepatitis (CAH).

Authors:  M Colombo; S J Vernace; F Paronetto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

3.  Studies on drug-induced lupus erythematosus in mice. II. Drug-induced smooth muscle and skeletal muscle antibodies.

Authors:  J H ten Veen
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

4.  Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.

Authors:  F J Dudley; M J O'Shea; S Sherlock
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

Review 5.  [Hepatitis-associated antigen: clinical and immunological significance].

Authors:  P A Berg
Journal:  Klin Wochenschr       Date:  1972-02-01

6.  Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease.

Authors:  F J Dudley; M J O'Shea; A Ajdukiewicz; S Sherlock
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

7.  Australia antigen and circulating lymphocytes in acute viral hepatitis (AVH).

Authors:  R Naccarato; U Fagliolo; R Farini
Journal:  Postgrad Med J       Date:  1971-04       Impact factor: 2.401

8.  Chronic viral hepatitis B in childhood. II. Immunological studies in serum and liver tissue and family studies.

Authors:  C Bosch; M Becker; H W Rotthauwe; W Arnold; G Hess
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

9.  Autoantibody pattern in non-A, non-B hepatitis.

Authors:  F Caredda; A d'Arminio Monforte; E Rossi; L Zampini; G de Bartolo; P L Meroni
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

10.  Evidence for hepatitis B and other virus infection in HBsAg-negative chronic active hepatitis.

Authors:  E Villa; P Jenkins; B Portmann; A L Eddleston; R Williams
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.